Profile data is unavailable for this security.
About the company
Shanghai Runda Medical Technology Co Ltd is a China-based company primarily engaged in the research, development, production and sales of medical devices and in vitro diagnostic reagents. The Company operates two businesses. The integrated services business provides a full-industry supply chain service to various medical laboratories, including product portfolio services, cold chain warehousing and logistics, regular instrument maintenance and repair, and localized rapid response repair services, integrated service and regional testing center service, as well as third-party laboratory testing services. The industrial business is primarily engaged in the research, development, production and manufacturing of in vitro diagnostic (IVD) products, as well as the development of digital information systems and software. The Company primarily operates its businesses in the domestic market.
- Revenue in CNY (TTM)7.40bn
- Net income in CNY-157.84m
- Incorporated1999
- Employees3.14k
- LocationShanghai Runda Medical Technology Co Ltd8F, Tower 1, Xinghui Center, No. 89Zhapu Road, Hongkou DistrictSHANGHAI 200085ChinaCHN
- Phone+86 2 168406213
- Fax+86 2 168406213
- Websitehttps://www.rundamedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOB Biotech Group Corp Ltd | 387.48m | 36.43m | 9.10bn | 529.00 | 245.45 | 10.83 | -- | 23.48 | 0.5838 | 0.5838 | 6.17 | 13.23 | 0.3938 | 1.50 | 7.30 | 732,482.30 | 3.70 | 7.24 | 4.41 | 8.64 | 57.87 | 64.53 | 9.40 | 16.21 | 1.07 | 14.22 | 0.0805 | 42.82 | 2.01 | 9.20 | -22.24 | -10.43 | 34.88 | -- |
| Sino Medical Sciences Technology Inc | 504.11m | 29.36m | 9.37bn | 691.00 | 317.65 | 10.36 | -- | 18.59 | 0.0706 | 0.0706 | 1.21 | 2.17 | 0.385 | 1.63 | 42.71 | 729,533.10 | 1.69 | -5.65 | 2.05 | -6.45 | 63.92 | 63.65 | 4.40 | -21.72 | 1.71 | 2.66 | 0.2102 | -- | 33.64 | 1.03 | 103.78 | -55.92 | -17.21 | -- |
| Shinva Medical Instrument Co Ltd | 9.58bn | 508.92m | 9.39bn | 8.14k | 18.50 | 1.20 | -- | 0.9807 | 0.837 | 0.837 | 15.78 | 12.91 | 0.6286 | 2.20 | 4.50 | 1,177,051.00 | 3.30 | 4.12 | 6.27 | 8.97 | 24.46 | 25.09 | 5.24 | 5.61 | 0.8863 | -- | 0.124 | 21.15 | 0.0874 | 2.71 | 5.75 | -4.29 | 14.30 | 26.58 |
| Shanghai Runda Medical Technology Co Ltd | 7.40bn | -157.84m | 9.77bn | 3.14k | -- | 2.34 | -- | 1.32 | -0.2609 | -0.2609 | 12.46 | 6.92 | 0.5237 | 3.68 | 1.46 | 2,360,202.00 | -0.5577 | 3.81 | -1.49 | 10.19 | 21.98 | 26.78 | -1.06 | 5.44 | 0.9723 | 1.16 | 0.5605 | 15.85 | -9.13 | 3.34 | -79.77 | -29.14 | -4.52 | -- |
| Shanghai Haohai Biological Tech Co Ltd | 2.52bn | 384.21m | 9.95bn | 2.16k | 28.37 | 1.91 | -- | 3.95 | 1.65 | 1.65 | 10.83 | 24.49 | 0.3512 | 1.53 | 7.84 | 1,169,728.00 | 4.94 | 4.58 | 5.96 | 5.26 | 69.13 | 70.39 | 14.07 | 14.67 | 3.24 | -- | 0.0656 | 42.37 | 1.64 | 10.95 | 1.04 | 2.55 | -1.86 | 14.87 |
| Qingdao Haier Biomedical Co Ltd | 2.26bn | 255.88m | 10.43bn | 2.81k | 40.46 | 2.42 | -- | 4.61 | 0.8144 | 0.8144 | 7.21 | 13.64 | 0.4008 | 4.31 | 5.12 | 806,199.10 | 4.68 | 10.87 | 5.92 | 14.12 | 45.31 | 49.21 | 11.67 | 24.08 | 2.41 | -- | 0.0205 | 28.14 | 0.1288 | 17.67 | -9.71 | 15.03 | -5.53 | 21.16 |
| Xiangyu Medical Co Ltd | 773.93m | 73.51m | 10.69bn | 2.34k | 139.56 | 5.28 | -- | 13.82 | 0.4789 | 0.4789 | 5.07 | 12.67 | 0.2548 | 1.01 | 11.40 | 330,597.70 | 2.35 | 8.54 | 3.26 | 10.17 | 65.98 | 66.78 | 9.22 | 28.37 | 0.9871 | -- | 0.2387 | 32.49 | -0.1717 | 11.71 | -54.68 | -4.41 | 83.55 | -- |
| Shanghai Microport EP MedTech Co Ltd | 458.70m | 52.26m | 11.05bn | 500.00 | 211.53 | 6.17 | -- | 24.10 | 0.111 | 0.111 | 0.9747 | 3.81 | 0.2395 | 1.33 | 6.85 | 917,403.00 | 2.73 | 0.9084 | 2.91 | 0.9579 | 58.24 | 64.95 | 11.39 | 4.09 | 10.17 | -- | 0.0032 | 0.00 | 25.51 | 28.61 | 815.36 | -- | 35.67 | -- |
| Beijing Wandong Medical Technolgy Co Ltd | 1.62bn | 14.41m | 11.26bn | 1.19k | 960.98 | 2.40 | -- | 6.95 | 0.0167 | 0.0167 | 2.26 | 6.66 | 0.2937 | 2.73 | 2.99 | 1,360,016.00 | 0.2623 | 4.51 | 0.304 | 5.21 | 31.59 | 42.82 | 0.8933 | 14.91 | 4.80 | -- | 0.0039 | 43.25 | 23.26 | 9.18 | -16.54 | -1.40 | -1.39 | 21.06 |
| Holder | Shares | % Held |
|---|---|---|
| New China Asset Management Co., Ltd.as of 31 Mar 2025 | 9.63m | 1.66% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 9.58m | 1.65% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 5.00m | 0.86% |
| Great Wall Fund Management Co., Ltd.as of 31 Mar 2025 | 4.60m | 0.79% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 4.48m | 0.77% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 4.21m | 0.73% |
| Caitong Securities Asset Management Co., Ltd.as of 30 Jun 2025 | 3.00m | 0.52% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2025 | 2.62m | 0.45% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 2.30m | 0.40% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 2.12m | 0.37% |
